Struthers Richard Scott

Insider profile

Performance

Overall performance
2.3

Performance over holding periods
4.2
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 27% 68% 82%
Transactions
10 20% Buy
34 71% Buy
47 69% Buy
Performance for realised trades
4.4
Average return 60%
Success rate 73%
Average holding period 220
Transactions 28
Struthers Richard Scott's trades of Crinetics Pharmaceuticals, Inc.'s stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-18 2026-03-16 PlS Planned sale
15,920 -25.5%
125.43
US$3,832,461
15,920 -25.5% 125.43 US$3,832,461
2026-03-18 2026-03-16 PlS Planned sale
48,527 -14.7%
167.09
US$4,715,610
48,527 -14.7% 167.09 US$4,715,610
2026-03-16 2026-03-16 PrS Proposed sale
20,324
66.39
US$4,082,383
20,324 66.39 US$4,082,383
2025-09-30 2025-09-26 PlS Planned sale
4,000 -3.6%
45.00
US$180,000
4,000 -3.6% 45.00 US$180,000
2025-09-26 2025-09-26 PrS Proposed sale
4,000
45.00
US$180,000
4,000 45.00 US$180,000
2025-03-21 2025-03-19 PlS Planned sale
875 -0.3%
34.83
US$30,476
875 -0.3% 34.83 US$30,476
2025-03-21 2025-03-19 PlS Planned sale
16,463 -4.8%
34.17
US$562,541
16,463 -4.8% 34.17 US$562,541
2024-12-04 2024-12-02 PlS Planned sale
10,000 -9.1%
57.57
US$575,700
10,000 -9.1% 57.57 US$575,700
2024-12-02 2024-12-02 PrS Proposed sale
10,000
57.27
US$572,700
10,000 57.27 US$572,700
2024-05-10 2024-05-08 PlS Planned sale
107,448 -29.4%
49.40
US$5,307,931
107,448 -29.4% 49.40 US$5,307,931
2024-05-10 2024-05-08 PlS Planned sale
107,448 -29.4%
49.40
US$5,307,931
107,448 -29.4% 49.40 US$5,307,931
2024-05-08 2024-05-08 PrS Proposed sale
107,448
49.40
US$5,308,092
107,448 49.40 US$5,308,092
2024-04-08 2024-04-04 PlS Planned sale
40,951 -14.7%
49.17
US$2,013,561
40,951 -14.7% 49.17 US$2,013,561
2024-04-04 2024-04-04 PrS Proposed sale
40,951
49.17
US$2,013,552
40,951 49.17 US$2,013,552
2023-11-06 2023-11-03 S Sale
199,082 -59.5%
30.56
US$6,083,946
199,082 -59.5% 30.56 US$6,083,946
2023-11-03 2023-11-03 PrS Proposed sale
199,082
29.95
US$5,962,505
199,082 29.95 US$5,962,505
2023-11-06 2023-11-02 S Sale
918 -0.7%
29.95
US$27,494
918 -0.7% 29.95 US$27,494
2023-11-02 2023-11-02 PrS Proposed sale
918
29.80
US$27,356
918 29.80 US$27,356
2023-07-13 2023-07-13 PrS Proposed sale
14,157
20.35
US$288,154
14,157 20.35 US$288,154
2023-07-13 2023-07-13 S Sale
14,157 -2.2%
20.35
US$288,095
14,157 -2.2% 20.35 US$288,095
2023-07-13 2023-07-12 S Sale
11,459 -1.7%
20.17
US$231,128
11,459 -1.7% 20.17 US$231,128
2023-07-12 2023-07-12 PrS Proposed sale
11,459
20.17
US$231,172
11,459 20.17 US$231,172
2023-07-13 2023-07-11 S Sale
24,384 -3.6%
20.14
US$491,094
24,384 -3.6% 20.14 US$491,094
2023-07-11 2023-07-11 PrS Proposed sale
24,384
20.14
US$491,118
24,384 20.14 US$491,118
2023-06-21 2023-06-16 S Sale
50,000 -6.8%
20.81
US$1,040,500
50,000 -6.8% 20.81 US$1,040,500
2023-06-16 2023-06-16 PrS Proposed sale
50,000
20.51
US$1,025,335
50,000 20.51 US$1,025,335
2022-04-15 2022-04-13 PlS Planned sale
69,176 -8.6%
27.53
US$1,904,256
69,176 -8.6% 27.53 US$1,904,256
2022-04-15 2022-04-13 PlS Planned sale
44,793 -5.3%
26.52
US$1,188,040
44,793 -5.3% 26.52 US$1,188,040
2022-04-15 2022-04-13 PlS Planned sale
24,674 -2.8%
25.42
US$627,329
24,674 -2.8% 25.42 US$627,329
2022-04-07 2022-04-05 PlS Planned sale
21,357 -2.4%
25.34
US$541,225
21,357 -2.4% 25.34 US$541,225
2020-12-04 2020-12-03 B Purchase
4,000 +inf%
13.10
US$52,400
4,000 +inf% 13.10 US$52,400
2020-12-04 2020-12-02 B Purchase
1,000 +inf%
12.60
US$12,600
1,000 +inf% 12.60 US$12,600
2020-07-17 2020-07-16 S Sale
17,500 -1.9%
14.46
US$253,108
17,500 -1.9% 14.46 US$253,108
2020-07-17 2020-07-15 S Sale
17,500 -1.9%
15.30
US$267,722
17,500 -1.9% 15.30 US$267,722